IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PILOTTO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.548
AS - Asia 6.201
EU - Europa 3.945
SA - Sud America 1.444
AF - Africa 156
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.294
SG - Singapore 2.381
CN - Cina 1.623
BR - Brasile 1.203
IT - Italia 1.046
HK - Hong Kong 708
DE - Germania 580
FR - Francia 512
VN - Vietnam 430
UA - Ucraina 412
BD - Bangladesh 382
FI - Finlandia 306
GB - Regno Unito 273
RU - Federazione Russa 218
TR - Turchia 196
IE - Irlanda 171
IN - India 134
CA - Canada 115
AR - Argentina 85
MX - Messico 84
NL - Olanda 77
CZ - Repubblica Ceca 58
PL - Polonia 56
ZA - Sudafrica 53
AT - Austria 50
ID - Indonesia 50
ES - Italia 48
IQ - Iraq 47
JP - Giappone 46
SE - Svezia 43
EC - Ecuador 35
CO - Colombia 32
SA - Arabia Saudita 31
VE - Venezuela 27
PK - Pakistan 25
MA - Marocco 22
EG - Egitto 20
BE - Belgio 19
UZ - Uzbekistan 17
CL - Cile 16
KE - Kenya 16
PY - Paraguay 14
JO - Giordania 13
LT - Lituania 13
PH - Filippine 13
AZ - Azerbaigian 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
CR - Costa Rica 9
NG - Nigeria 9
PT - Portogallo 9
UY - Uruguay 9
AU - Australia 8
CH - Svizzera 8
JM - Giamaica 8
AL - Albania 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
MY - Malesia 7
PA - Panama 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
RO - Romania 6
SN - Senegal 6
ET - Etiopia 5
GT - Guatemala 5
OM - Oman 5
PS - Palestinian Territory 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
HR - Croazia 3
KR - Corea 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
GD - Grenada 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
MU - Mauritius 2
NI - Nicaragua 2
Totale 21.284
Salva come PNG Salva come JPEG
Città #
Singapore 1.268
Ashburn 965
Fairfield 884
Hong Kong 704
Woodbridge 575
San Jose 517
Houston 404
Seattle 386
The Dalles 372
New York 364
Beijing 327
Cambridge 327
Jacksonville 320
Wilmington 297
Los Angeles 270
Ann Arbor 262
Princeton 236
Helsinki 205
Lauterbourg 193
Chandler 189
Milan 175
Istanbul 170
Ho Chi Minh City 154
Dublin 152
Munich 151
Buffalo 131
Chicago 125
Council Bluffs 107
Dallas 107
Des Moines 100
São Paulo 100
Brescia 98
Dearborn 97
Nanjing 94
Redondo Beach 88
Hanoi 86
San Diego 74
Moscow 73
Santa Clara 70
London 62
Nuremberg 62
Rome 61
Turku 57
San Francisco 56
Orem 54
Frankfurt am Main 53
Warsaw 53
Shenyang 50
Shanghai 49
Changsha 44
Salt Lake City 43
Guangzhou 38
Nanchang 37
Montreal 36
Toronto 36
Rio de Janeiro 34
Brno 33
Chennai 33
Tokyo 33
Belo Horizonte 31
Atlanta 30
Boardman 29
Brooklyn 29
Lappeenranta 29
Mexico City 29
Tampa 28
Denver 26
Jinan 26
Naples 26
Tianjin 26
Vienna 26
Lancaster 25
Stockholm 25
Johannesburg 24
Hangzhou 23
Ningbo 23
Brasília 22
Da Nang 22
Hebei 21
Romola 21
Olomouc 20
Verona 20
Zhengzhou 20
Boston 19
Elk Grove Village 19
Norwalk 19
Phoenix 19
Brussels 18
Dhaka 18
Poplar 18
Charlotte 17
Guarulhos 17
Turin 17
Düsseldorf 16
Florence 16
Kunming 16
Amsterdam 15
Kyiv 15
Porto Alegre 15
Quito 15
Totale 13.031
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 349
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 331
COVID-19 impact on consecutive neurological patients admitted to the emergency department 257
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 232
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 226
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 209
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 199
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 199
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 195
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 187
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 186
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 185
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 179
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 177
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 176
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 173
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 168
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 167
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 165
Vascular risk factors and cognition in Parkinson's disease 161
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 160
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 158
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 158
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 157
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 157
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 153
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 152
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 149
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 149
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 145
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 143
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 137
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 137
Central serous chorioretinopathy: Pathogenesis and management 136
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 135
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 134
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 133
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 133
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 133
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 132
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 132
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 131
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 131
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 131
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 130
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 130
Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions 129
Long-term neurological outcome in patients presenting with encephalitis 128
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 125
Disease-modifying therapies in frontotemporal lobar degeneration. 125
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 125
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 124
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 123
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 123
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 123
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 122
Dopaminergic deficits along the spectrum of Alzheimer’s disease 121
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 121
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 121
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 120
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 118
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 118
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study 117
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 116
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 116
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 116
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications 115
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 114
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 114
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 114
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 113
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 113
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 112
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 111
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 111
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 111
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 111
Metabolic patterns across core features in dementia with lewy bodies 110
Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease 108
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 108
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 108
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 107
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 106
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 106
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 104
Family History in Parkinson's Disease: A National Cross-Sectional Study 103
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 103
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 102
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 102
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 101
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 100
Occipital atrophy signature in prodromal Lewy bodies disease 99
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 99
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 99
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients 97
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 96
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 96
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 96
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 96
Totale 13.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20254.065 56 26 47 515 394 261 264 177 488 393 945 499
2025/20269.321 794 1.114 724 1.234 720 631 1.267 505 597 769 634 332
Totale 21.612